Longevience AB

Stockholm – SWE

AgeViva promotes anti-aging and longevity

  • A cutting-edge dietary supplement from yeast cells
  • Reduces inflammation and oxidative stress
  • Supports brain and nerve growth factors
  • It has Anti-parkinsonian effects
  • Longevity is of interest for the traditional pharma industry.
  • The longevity market estimates an annual growth rate (CAGR) of 22.2 %.
  • The combined markets for Longevity and diseases such as Type 2 diabetes that can be treated with longevity drugs was $127B in 2021.

Founding year

2025

Industry

Dietary supplement

Thomas Lenz

CEO
Milmed Unico AB have developed a probiotic therapeutic instrument, with proven effect within longevity/antiaging. We have in studies showed effects in six main hallmarks for Longevity. Our mission is to launch our patended product AgeViva globally, starting 2025.
businessman-working-at-laptop-taking-notes-in-not-2022-12-16-22-27-36-utc.jpg
thomas-lenz

Thomas Lenz

CEO
Milmed Unico AB have developed a probiotic therapeutic instrument, with proven effect within longevity/antiaging. We have in studies showed effects in six main hallmarks for Longevity. Our mission is to launch our patended product AgeViva globally, starting 2025.